Cooper Companies COO
NASDAQ COO
$53.91 -0.26 (-0.48%)
At close: Sep 11, 2026 · 4:00 PM EDT

Cooper Companies (COO) Liabilities and Shareholders Equity (2009 - 2026)

Cooper Companies (COO) posted Liabilities and Shareholders Equity of $12.5 billion for Q2 2026, little changed on a QoQ basis from $12.4 billion in Q1 2026, and up 0.55% year-over-year from $12.4 billion in Q2 2025.

Analysis

Cooper Companies (COO) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Cooper Companies has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $12.5 billion in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 0.55% year-over-year to $12.5 billion in Q2 2026; TTM through Apr 2026 was $49.7 billion, a 1.26% increase from a year earlier, with the FY2025 full-year figure at $12.4 billion, up 0.65% from the prior year.
  • Liabilities and Shareholders Equity was $12.5 billion for Q2 2026 at Cooper Companies, roughly flat from $12.4 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $12.5 billion in Q2 2026, with the low at $11.5 billion in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $12.0 billion, with a median of $12.0 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity soared 30.72% in 2022, then declined 2.02% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $11.5 billion in 2022, then gained by 1.45% to $11.7 billion in 2023, then advanced by 5.63% to $12.3 billion in 2024, then climbed by 0.65% to $12.4 billion in 2025, then climbed by 0.71% to $12.5 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $12.5 billion (Q2 2026), $12.4 billion (Q1 2026), and $12.4 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn 20.88 Bn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 93.31 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 13.87 Bn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn 31.10 Bn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 6.46 Bn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 10.74 Bn
10 Cooper Companies 10.51 Bn 10.37 Bn 735.40 Mn 12.48 Bn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 12.48 Bn
Jan 31, 2026 12.42 Bn
Oct 31, 2025 12.39 Bn
Jul 31, 2025 12.38 Bn
Apr 30, 2025 12.41 Bn
Jan 31, 2025 12.22 Bn
Oct 31, 2024 12.32 Bn
Jul 31, 2024 12.11 Bn
Apr 30, 2024 12.05 Bn
Jan 31, 2024 12.03 Bn
Oct 31, 2023 11.66 Bn
Jul 31, 2023 11.70 Bn
Apr 30, 2023 11.54 Bn
Jan 31, 2023 11.56 Bn
Oct 31, 2022 11.49 Bn
Jul 31, 2022 11.55 Bn
Apr 30, 2022 11.78 Bn
Jan 31, 2022 11.66 Bn
Oct 31, 2021 9.61 Bn
Jul 31, 2021 9.61 Bn